Streptococcus Pneumoniae Polysaccharide Conjugated To Tetanus Toxoid
Streptococcus pneumoniae polysaccharide conjugated to tetanus toxoid is a vaccine component where pneumococcal capsular polysaccharides are conjugated to inactivated tetanus toxin as the carrier protein to enhance immunogenicity and produce T-cell-dependent antibody responses. Tetanus toxoid is an approved, well-characterized carrier protein that effectively promotes T-helper cell responses required for immunological memory to polysaccharide antigens. This conjugation is used in some pneumococcal vaccine serotype-specific conjugates.
治疗领域
作用机制
As a monoclonal antibody, it binds with high specificity to its target antigen, modulating the immune response through mechanisms including receptor blockade, immune cell engagement, or targeted cytotoxicity.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
As a monoclonal antibody, it binds with high specificity to its target antigen, modulating the immune response through mechanisms including receptor blockade, immune cell engagement, or targeted cytotoxicity.
HBD / HBA
- / -
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
常见问题
Streptococcus pneumoniae polysaccharide conjugated to tetanus toxoid is a vaccine component where pneumococcal capsular polysaccharides are conjugated to inactivated tetanus toxin as the carrier protein to enhance immunogenicity and produce T-cell-dependent antibody responses. Tetanus toxoid is an approved, well-characterized carrier protein that effectively promotes T-helper cell responses required for immunological memory to polysaccharide antigens. This conjugation is used in some pneumococcal vaccine serotype-specific conjugates.
As a monoclonal antibody, it binds with high specificity to its target antigen, modulating the immune response through mechanisms including receptor blockade, immune cell engagement, or targeted cytotoxicity.
Yes, Streptococcus Pneumoniae Polysaccharide Conjugated To Tetanus Toxoid is an approved drug. It has reached clinical phase 4. It is classified as a Vaccine component.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6068366. Open-access bioactivity database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="streptococcus-pneumoniae-polysaccharide-conjugated-to-tetanus-toxoid"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/streptococcus-pneumoniae-polysaccharide-conjugated-to-tetanus-toxoid/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/streptococcus-pneumoniae-polysaccharide-conjugated-to-tetanus-toxoid/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/streptococcus-pneumoniae-polysaccharide-conjugated-to-tetanus-toxoid/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="streptococcus-pneumoniae-polysaccharide-conjugated-to-tetanus-toxoid"></drugfyi-drug>